This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Atrial Septal Defects
Information about Atrial Septal Defects: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Atrial Septal Defects
Most recent studies have shown that Atrial Septal Defects shares some biological mechanisms with atrial-septal-defect-within-oval-fossa, cardiac-arrhythmia, congenital-abnormality, congenital-heart-defects, congenital-heart-disease, foramen-ovale-patent, heart-diseases, heart-failure, heart-septal-defects, hypertensive-disease, mitral-valve-insufficiency, patent-ductus-arteriosus, pulmonary-hypertension, pulmonary-stenosis, regurgitation, stenosis, tetralogy-of-fallot, transposition-of-great-vessels, ventricular-septal-defects.
Among the many pathways, these few ones have gauged particular interests from scientists studying Atrial Septal Defects, and have been seen in publications frequently: Aging, Cardiac Conduction, Coagulation, Dehiscence, Ductus Arteriosus Closure, Fibrinolysis, Foramen Ovale Closure, Heart Development, Hemostasis, Inflammatory Response, Localization, Metaphase, Oxygen Transport, Pathogenesis, Secretion, Segmentation, Translation, Transport, Transposition, Vasoconstriction
Quite a number of genes have been found to play important roles in Atrial Septal Defects, such as AGA, AMY2A, ARSD, AURKA, BLOC1S6, CASP1, CES2, CPB1, EPB42, GATA4, GNL3, KRAS, NKX2-5, PAH, PRH1, RANGAP1, SLC17A5. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.